Kyowa Kirin Co., Ltd. (OTCMKTS:KYKOF – Get Free Report) traded down 11.4% during trading on Thursday . The company traded as low as $13.28 and last traded at $13.28. 100 shares were traded during mid-day trading, a decline of 95% from the average session volume of 2,220 shares. The stock had previously closed at $15.00.
Kyowa Kirin Price Performance
The stock has a 50 day moving average of $15.78 and a 200 day moving average of $18.10.
Kyowa Kirin Company Profile
Kyowa Kirin Co, Ltd. engages in the research, development, manufacturing, marketing, and import/export of pharmaceuticals for oncology, nephrology, central nervous system, and immunology therapeutic areas in Japan, the United States, rest of the Americas, Europe, Asia, and internationally. Its products include ALLELOCK, an antihistamine agent for patients with various types of allergies; CONIEL, a calcium channel blocker for hypertension and angina pectoris; Crysvita, a recombinant human monoclonal IgG1 antibody against the phosphaturic hormone fibroblast growth factor 23; ESPO, a glycoprotein and human erythropoietin; NESP, an erythropoiesis stimulating agent; and GRAN, a human colony-stimulating factor.
Featured Articles
- Five stocks we like better than Kyowa Kirin
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Cerence AI: One-Hit Wonder or Long-Term Winner After NVIDIA Pact?
- How to Invest in Small Cap Stocks
- UnitedHealth Group Pulls Back Into Another Healthy Opportunity
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Micron Technology: Riding the AI Wave to Long-Term Growth
Receive News & Ratings for Kyowa Kirin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kyowa Kirin and related companies with MarketBeat.com's FREE daily email newsletter.
